Viread 123 mg film-coated tablets
Sponsors
Gilead Sciences Inc., Gilead Sciences Inc., Gilead Sciences Inc.
Conditions
HIV-1Hepatitis B Infection
Phase 3
A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Patients with Chronic Hepatitis B Infection
CompletedCTIS2024-517526-26-00
Start: 2012-12-06End: 2025-06-05Target: 23Updated: 2024-11-07
A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Switching to a Regimen of Broadly Neutralizing
Antibodies Teropavimab and Zinlirvimab in Combination with Capsid Inhibitor Lenacapavir Twice Yearly in Virologically Suppressed Adults with HIV-1 Infection on Stable Oral Treatment Regimens
Not yet recruitingCTIS2025-524336-19-00
Target: 10Updated: 2026-07-21